Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Barbara Madej-Czerwonka"'
Publikováno v:
Annals of Agricultural and Environmental Medicine, Vol 29, Iss 1, Pp 152-156 (2021)
Introduction Basal cell carcinoma (BCC) is the most common form of skin cancer. The hallmarks of this carcinoma are the absence of distant metastases and local malignancy. Metatypical basal cell carcinoma (MTBBC) is rare variant that it is considered
Externí odkaz:
https://doaj.org/article/ff6c2792938b4f808c11c70e685dc9fb
Autor:
Rafal Wojcik, Katarzyna Adanczyk, Dorota Adamczyk, Krzysztof Kozak, Maciej Czerwonka, Mateusz Dziedzic, Barbara Madej–Czerwonka
Publikováno v:
Journal of Education, Health and Sport, Vol 8, Iss 8, Pp 180-191 (2018)
Gynecomastia is a benign enlargement of the mammary gland in males. Nowadays it is a common disorder of all ages, including newborns, adolescents and adults. It may be bilateral or unilateral enlargement of the breast. Gynecomastia may be a severe pr
Externí odkaz:
https://doaj.org/article/b5ea61b98db445d5a4252845e4f98312
Autor:
Grzegorz Adamczuk, Ewelina Humeniuk, Kamila Adamczuk, Barbara Madej-Czerwonka, Jarosław Dudka
Publikováno v:
Annals of Agricultural and Environmental Medicine. 30:65-76
Publikováno v:
Current Issues in Pharmacy and Medical Sciences. 35:1-5
World wide, breast cancer is the most common malignancy in women. Despite an increased incidence of this cancer, the mortality rates have been maintained at the same level. This is due to the continuous development of therapeutic, as well as diagnost
Autor:
Joanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, Barbara Madej-Czerwonka, Agnieszka Korga-Plewko
Publikováno v:
International journal of molecular sciences. 23(10)
Cancer is the second most common cause of death worldwide after cardiovascular diseases. The development of molecular and biochemical techniques has expanded the knowledge of changes occurring in specific metabolic pathways of cancer cells. Increased
Autor:
Barbara Madej-Czerwonka
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 34, Iss 1, Pp 17-19 (2021)
The paper aims to introduce the case of an extensive breast malignancy – phyllodes tumor. This type of breast neoplasm is relatively rare. Indeed, it accounts for only 0.3-1% of all breast malignant tumours. In the paper, patient, disease, and trea
Autor:
Jacek Bogucki, Elżbieta Kołodziej, Marcin Nicoś, Anna Makuch-Kocka, Paweł Krawczyk, Tomasz Kubrak, Janusz Kocki, Daniel P Zalewski, Barbara Madej-Czerwonka, Przemysław Kołodziej, Anna Bogucka-Kocka, Bartosz J. Płachno, Agnieszka Karczmarczyk
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 2061, p 2061 (2021)
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2061, p 2061 (2021)
Volume 22
Issue 4
There is an urgent need to seek new molecular biomarkers helpful in diagnosing and treating breast cancer. In this elaboration, we performed a molecular analysis of mutations and expression of genes within the PI3K/Akt/mTOR pathway in patients with d
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 31, Iss 3, Pp 131-134 (2018)
Breast cancer is the most common cancer among Polish women [1], thus, the problem of surgical treatment of breasts, especially with regard to conserving and/or reconstruction surgery, is extensively discussed. Currently, in Poland, efforts are made t
Autor:
Barbara Madej-Czerwonka, Ryszard Maciejewski, Magdalena Idziak, Lidia Kotuła, Janusz Kocki, Barbara Cuch, Anna Polaczek
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 28, Iss 2, Pp 115-119 (2015)
Attention Deficit Hyperactivity Disorder is the full name of the disease commonly deemed ADHD. This disease is most frequently diagnosed in childhood, and it affects up to 12 % of all children world-wide. The current clinical criteria (the base for d
Autor:
Barbara Madej-Czerwonka
Publikováno v:
Current Issues in Pharmacy and Medical Sciences. 26:35-39
Breast cancer is the most common malignant neoplasm diagnosed in Polish women. The results of treatment for breast cancer in Poland are worse than those received in highly developed European countries. The factor that is decisive in reducing mortalit